The Discounted Cash Flow (DCF) valuation of Cytosorbents Corp (CTSO) is (170.42) USD. With the latest stock price at 3.90 USD, the upside of Cytosorbents Corp based on DCF is -4469.8%.
Based on the latest price of 3.90 USD and our DCF valuation, Cytosorbents Corp (CTSO) is a sell. selling CTSO stocks now will result in a potential gain of 4469.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 7.3% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (422.70) - (110.73) | (170.42) |
| Upside | -10938.6% - -2939.3% | -4469.8% |